COVID Vaccine Developer/Manufacturer Announcements [selected]

Milestones :: Perspectives :: Research

 

COVID Vaccine Developer/Manufacturer Announcements [selected]

 

AstraZeneca
Press Releases – No new digest announcements identified

 

Janssen/JNJ
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company’s COVID-19 Vaccine Candidate
:: Up to 400 million doses of the Company’s single-shot vaccine candidate will be made available to African Union member states
:: Availability of the vaccine is subject to national regulatory approvals
:: Data have demonstrated vaccine candidate protects against COVID-19 related hospitalization and death in broad geographic regions, including those with variants of significant concern
Mar 29, 2021, 03:09 ET

 

Moderna
Press Releases
April 1, 2021
Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine

March 31, 2021
Moderna to Host Second Annual Virtual Vaccines Day on April 14, 2021

March 29, 2021
Moderna Announces Shipment of 100 Millionth Dose of its COVID-19 Vaccine to the U.S. Government

 

Novavax
News
GSK to support manufacture of Novavax’ COVID-19 vaccine
– GSK to support manufacture of up to 60 million doses of Novavax’ COVID-19 vaccine
– Manufacturing to take place at GSK UK facility at Barnard Castle
Mar 29, 2021, 16:02 ET

 

Pfizer
Recent Press Releases
04.01.2021
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

03.31.2021
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

 

Serum Institute
NEWS & ANNOUNCEMENTS – No new digest announcements identified

 

Sinovac
Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine
April 01, 2021